None listed
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Medanta Institute of Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Healthy adult (18-60 years) individuals receiving anti SARS CoV 2 vaccination, irrespective of their pre-vaccination serological status, providing informed consent for sampling.
Exclusion criteria
Exclusion criteria: All individuals 60 years. Non consenting for sampling Individuals who develop COVID 19 infection during study period will be excluded from study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of quantitative (titer) IgG neutralizing antibody as well the generation of memory T cell responses to viral antigens will be measured in the studyTimepoint: Visit1: Blood collection and 1st dose of vaccine Visit2: Blood collection at 15th day post 1st dose of vaccine Visit3: Blood collection and 2nd dose of vaccine Visit 4: Blood collection at 15th day post 2nd dose Visit 5:Blood collection 6 month post first dose | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of these parameters with incidence of infection for a follow up period of 6 months will provide correlates of protection achieved from vaccination vis-a-vis natural infectionTimepoint: 6 month follow up 1 month for statistical analysis and manuscript | — |
Countries
India
Contacts
Public ContactDr Pooja Sharma
Medanta The Medicity
Outcome results
None listed